Dynamic quotes: Off
|
Company Description (as filed with the SEC)
Neogen Corporation and subsidiaries (Neogen or the Company) develop, manufacture, and market a diverse line of products dedicated to food and animal safety. The Company’s food safety segment consists primarily of diagnostic test kits and complementary products (e.g., dehydrated culture media) marketed by company sales personnel in North America, the United Kingdom and other parts of Europe, Mexico and Brazil, and by distributors elsewhere to food producers and processors to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, drug residues, pesticide residues and general sanitation concerns. The diagnostic test kits are generally less expensive, easier to use and provide greater accuracy and speed than conventional diagnostic methods. ... More ...
Analyst Info |
|
| Annual EPS Est: | $0.94 |
| Quarterly EPS Est: | 0.31 |
| PEG Ratio: | 2.65 |
|
Mean Recommendation: View Summary / View All |
1.6 |
Data is provided by Zacks Investment Research

